Preclinical Trials of L-Lysine-a-Oxidase, an Antitumor Enzyme

The effect of L-lysine-a-oxidase from a representative of the Trichoderma genus on the humoral immune response to protein antigens was studied. It was shown that repeated fife-fold intravenous administrations of L-lysine-a-oxidase in a dose of 35 U/kg had no depressive action on the humoral immunity...

Full description

Saved in:
Bibliographic Details
Main Authors: V. M. Podboronov, A. E. Kuzovnikov, A. K. Zaitseva, I. P. Smirnova
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/332
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effect of L-lysine-a-oxidase from a representative of the Trichoderma genus on the humoral immune response to protein antigens was studied. It was shown that repeated fife-fold intravenous administrations of L-lysine-a-oxidase in a dose of 35 U/kg had no depressive action on the humoral immunity. The enzyme had no suppressive effect on the delayed type hypersensitivity to xenogenous erythrocytes. The use of L-lysine-a-oxidase in a therapeutic dose or in a twice as higher dose had no reliable effect on the leukocyte migration capacity vs. the control.
ISSN:0235-2990